Sarepta Therapeutics (SRPT) Other Working Capital Changes (2013 - 2026)

Sarepta Therapeutics' Other Working Capital Changes history runs 14 years deep, the most recent figure standing at -$274.9 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 221.93% year-over-year to -$274.9 million; the TTM figure through Mar 2026 stood at -$109.7 million (down 333.65% YoY), while the FY2025 annual figure was $69569.0, down 99.28% from the prior year.
• Other Working Capital Changes was -$274.9 million for Q1 2026 at Sarepta Therapeutics, down from $49.6 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $122.7 million in Q2 2025 to a low of -$274.9 million in Q1 2026.
• Historically, Other Working Capital Changes has averaged -$16.3 million across 5 years, with a median of -$7.1 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes plunged 323.9% in 2024, then jumped 1122.15% in 2025.
• A 5-year view of Other Working Capital Changes shows it stood at -$22.5 million in 2022, then jumped by 79.13% to -$4.7 million in 2023, then soared by 1060.61% to $45.1 million in 2024, then rose by 9.98% to $49.6 million in 2025, then plunged by 654.37% to -$274.9 million in 2026.
• The last three Other Working Capital Changes figures came in at -$274.9 million (Q1 2026), $49.6 million (Q4 2025), and -$7.1 million (Q3 2025), per Business Quant data.